volume 5, issue 7, P495-506 2013
DOI: 10.18632/aging.100579
View full text
Sign up to set email alerts

Abstract: In recent years, the wealth of basic science research supporting resveratrol's potential to treat, delay, and even prevent age-related chronic diseases has led to a number of human clinical trials. While such translational research has yielded promising results in clinical populations, recently published conflicting results from studies evaluating resveratrol's potential for primary prevention of chronic disease in healthy / asymptomatic individuals have generated considerable controversy and do not initially …

Expand abstract